On April 21st 2008, the Kinshasa School of Public Health (ESP Kin), the Biamba Marie Mutombo Hospital (BMMH), and the Swiss Tropical and Public Health Institute (Swiss TPH) signed a tripartite agreement to create the Alliance for Clinical Research and Clinical Epidemiology in the DRC (ARCEAU-RDC). The overall objective of this Alliance was to strengthen the capacities in clinical and epidemiological research in the Democratic Republic of the Congo.
Funding a five years period from 2007 – 2012 was granted by the Bill & Melinda Gates Foundation. In this period, two clinical trial centers with laboratories were created at the ESP Kin and BMMH, the foundation for a quality system was laid and a significant number of people trained to conduct clinical trials in various courses and trainings. The Alliance triggered collaboration mainly in the field of malaria and several clinical trials, large scale research projects and capacity building projects were conducted until today mainly in collaboration between Swiss TPH and the ESP Kin.
On April 4th 2106, the Alliance contract was renewed and expanded by adding the Clinical Pharmacology and Pharmacovigilance Unit of the University of Kinshasa (UPC-PV).
The Alliance will continue the work on malaria but expand its activities into other areas which may include other infectious but also non-communicable diseases like cancer and diabetes, and also cover drug safety and pharmacovigilance. Together, the four partner institutions, each with their own network of collaborations, will unite a unique set of skills and capacities which will strengthen Kinshasa and the DRC as a research location.